DUSA PHARMACEUTICALS INC
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: DUSA PHARMACEUTICALS INC, 10-Q, 2000-08-11
Next: BELDEN & BLAKE CORP /OH/, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM The
Company's unaudited consolidated balance sheets, consolidated statements of
operations, and consolidated statements of cash flows AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FORM 10-Q for the fiscal period ending June
30, 2000
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      20,069,284
<SECURITIES>                                43,349,913
<RECEIVABLES>                                1,288,953
<ALLOWANCES>                                         0
<INVENTORY>                                    315,935
<CURRENT-ASSETS>                            65,138,733
<PP&E>                                       1,105,553
<DEPRECIATION>                                  64,339
<TOTAL-ASSETS>                              67,693,292
<CURRENT-LIABILITIES>                        1,062,221
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    94,060,613
<OTHER-SE>                                (38,627,747)
<TOTAL-LIABILITY-AND-EQUITY>                67,693,292
<SALES>                                              0
<TOTAL-REVENUES>                               942,627
<CGS>                                                0
<TOTAL-COSTS>                                  440,828
<OTHER-EXPENSES>                             1,941,727
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,439,928)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,439,928)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,439,928)
<EPS-BASIC>                                     (0.11)
<EPS-DILUTED>                                   (0.11)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission